Diaceutics appoints new VP of marketing
9th Apr 2024 12:34
(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.
Read moreDirector dealings: BAT, Diaceutics execs make investments
6th Jun 2023 13:47
(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.
Read moreDiaceutics shares resume trading after HSBC buys SVB UK
13th Mar 2023 11:10
(Sharecast News) - Pharmaceutical technology and service provider Diaceutics announced at mid-morning on Monday that the temporary suspension of its shares on AIM would be lifted.
Read moreDiaceutics secures $2m multi-year contract with global pharma company
13th Jun 2022 10:30
(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceutical company to deliver customised data insights via its DXRX platform.
Read moreDiaceutics inks five-year deal with existing pharma partner
5th May 2022 12:58
(Sharecast News) - Diaceutics announced a five-year, multi-product subscription contract with an unnamed "top 30" global pharma company on Thursday, to deliver customised data insights via its 'DXRX' platform.
Read moreDiaceutics secures $1m subscription contract with 'leading life sciences company'
14th Dec 2021 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Tuesday that it had secured a $1.0m contract with a "leading life sciences company" to provide data feed from its DXRX platform.
Read moreDiaceutics delivers 'strong start' to 2021 despite ongoing pandemic
8th Jul 2021 09:56
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Thursday that it had delivered "a strong start to the 2021 financial year", in line with management's expectations and despite the ongoing Covid-19 pandemic.
Read moreDiaceutics secures multiple contracts with 'leading' pharma firms
24th Jun 2021 10:15
(Sharecast News) - Diagnostics commercialisation company Diaceutics has secured four contracts with two "leading pharmaceutical companies" to solve real-world testing hurdles for inherited retinal disease.
Read moreDiaceutics wins data deal with unnamed pharma firm
1st Apr 2021 16:05
(Sharecast News) - Diaceutics has secured a data licensing agreement with an unnamed global pharmaceutical company to provide Covid-19 testing data insights in the US, it announced on Thursday, enabled by its proprietary diagnostic network 'DXRX'.
Read moreDiaceutics pleased with 2020 performance
11th Jan 2021 16:12
(Sharecast News) - Diaceutics updated the market on its trading in 2020 on Monday, reporting that its revenue and adjusted EBITDA for the year ended 31 December were expected to be around £12.6m, down from £13.4m, and £0.5m, down from £2.2m respectively, with EBITDA breakeven.
Read moreDiaceutics shares rise as it launches new diagnostic development platform
28th Oct 2020 13:48
(Sharecast News) - Diaceutics announced the launch of its 'DXRX - The Diagnostic Network digital platform on Wednesday, which it said was designed to accelerate the development and commercialisation of precision medicine diagnostics using a new operating model.
Read moreDiaceutics wins ?1m pharmaceutical client contract
22nd Jul 2020 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics announced a new, "significant" client contract win with an unnamed pharmaceutical company on Wednesday.
Read moreDiaceutics builds on strong Q1, trades in line
8th Jul 2020 08:06
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Wednesday that it had built on its good start to the financial year, with trading in the first half in line with expectations.
Read moreDiaceutics raising £20.5m ahead of launch of new platform
11th Jun 2020 12:33
(Sharecast News) - Diagnostics commercialisation company Diaceutics has conditionally raised £20.5m before expenses, through a placing of 14,137,931 new shares at 145p each to existing and new investors in two tranches, it announced on Thursday.
Read moreDiaceutics maintains expectations after first quarter
19th May 2020 10:56
(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.
Read more